FDA issues Emergency Use Authorization to Roche COVID-19 test that aims to test vaccines’ antibody response

The Elecsys ® Anti-SARS-CoV-2 S specifically detects antibodies against the spike protein and appears to be geared toward measuring the antibody response produced by the vaccines currently under review. It was approved in the EU in mid-September.

Source:

Biospace Inc.